The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
NivoReach: Integrated study to demonstrate similarity of JPB898 to reference nivolumab in combination with ipilimumab in patients with advanced melanoma.
 
Piotr Rutkowski
Honoraria - Bristol-Myers Squibb; Genesis Pharma; Medison; Merck; MSD; Novartis; Pfizer; Pierre Fabre; Sanofi
Consulting or Advisory Role - Amgen; AstraZeneca; Blueprint Medicines; Bristol-Myers Squibb; MSD; Novartis; Philogen; Pierre Fabre
Speakers' Bureau - Novartis; Pfizer; Pierre Fabre
Research Funding - Bristol-Myers Squibb (Inst); Novartis (Inst); Pierre Fabre (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Orphan Europe; Pierre Fabre
 
Dimitrios Bafaloukos
No Relationships to Disclose
 
Andreia Melo
Honoraria - AstraZeneca; BMS; GlaxoSmithKline; MSD Oncology; Novartis; Roche; Sanofi
Consulting or Advisory Role - AstraZeneca; GlaxoSmithKline; MSD; Novartis
Research Funding - AstraZeneca (Inst); BMS Brazil (Inst); Clovis Oncology (Inst); MSD Oncology (Inst); Novartis (Inst); Roche (Inst)
Travel, Accommodations, Expenses - MSD Oncology
 
Claudia Hemmelmann
Employment - Hexal AG / Sandoz Inc
Stock and Other Ownership Interests - Hexal AG / Sandoz Inc
 
Samik Banerjee
Employment - Sandoz
Stock and Other Ownership Interests - Sandoz
 
NivoReach Investigators
No Relationships to Disclose